Cargando…
To bind or not to bind: Cistromic reprogramming in prostate cancer
The term “cistrome” refers to the genome-wide location of regulatory elements associated with transcription factor binding-sites. The cistrome of key regulatory factors in prostate cancer etiology are substantially reprogrammed and altered during prostatic transformation and disease progression. For...
Autores principales: | Shen, Michelle, Demers, Léa-Kristine, Bailey, Swneke D., Labbé, David P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539323/ https://www.ncbi.nlm.nih.gov/pubmed/36212399 http://dx.doi.org/10.3389/fonc.2022.963007 |
Ejemplares similares
-
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer
por: Baca, Sylvan C., et al.
Publicado: (2021) -
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
por: Pomerantz, Mark M., et al.
Publicado: (2015) -
ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss
por: Chen, Yu, et al.
Publicado: (2013) -
Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-κB cistrome to reprogram the prostate cancer cell transcriptome
por: Malinen, Marjo, et al.
Publicado: (2017) -
Limited conservation in cross-species comparison of GLK transcription factor binding suggested wide-spread cistrome divergence
por: Tu, Xiaoyu, et al.
Publicado: (2022)